指南与共识耳科与耳神经小儿耳鼻咽喉

临床实践指南:年龄相关性听力损失

Clinical Practice Guideline: Age-Related Hearing Loss.
指南 / 共识 · Otolaryngol Head Neck Surg · 2024-01-01

本指南由耳鼻咽喉头颈外科领域制定,针对50岁及以上人群的年龄相关性听力损失,提出11条关键行动声明,其中3条为强推荐(听力筛查阳性后获取或转诊完成纯音测听、提供或转诊进行助听器验配、助听器验配后仍有持续言语识别困难时转诊评估人工耳蜗植入),其余为推荐或可选建议。

要点

  • 50岁及以上人群在就诊时应筛查听力损失(推荐)。
  • 筛查提示听力损失者应获取或转诊完成纯音测听(强推荐)。
  • 助听器验配后仍有持续言语识别困难者应转诊评估人工耳蜗植入(强推荐)。

核心结论

  • 指南旨在识别质量改进机会,为临床医生提供关于年龄相关性听力损失识别与管理的可信、循证建议。

研究设计与样本

  • 指南制定小组(GDG)制定临床实践指南,目标患者为50岁及以上任何个体,目标受众为所有诊疗环境中的全体临床医生。

主要发现

  • 年龄相关性听力损失在50岁及以上人群中普遍但常诊断不足、治疗不足,与痴呆、抑郁、心血管疾病和跌倒等健康风险相关。

关键数值与推荐

  • KAS 4(强推荐):若筛查提示听力损失,临床医生应获取或转诊至能获取纯音测听的临床医生。
  • KAS 8(强推荐):临床医生应提供或转诊至能提供适当验配放大的临床医生。
  • KAS 9(强推荐):患者已适当验配放大但仍有持续听力困难和言语识别差时,临床医生应转诊评估人工耳蜗植入候选资格。
  • KAS 1(推荐):临床医生应在医疗就诊时对50岁及以上患者筛查听力损失。
  • KAS 2(推荐):若筛查提示听力损失,临床医生应使用耳镜检查耳道和鼓膜,或转诊至能检查耳部以排查耵聍栓塞、感染或其他异常的临床医生。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Age-related hearing loss (ARHL) is a prevalent but often underdiagnosed and undertreated condition among individuals aged 50 and above. It is associated with various sociodemographic factors and health risks including dementia, depression, cardiovascular disease, and falls. While the causes of ARHL and its downstream effects are well defined, there is a lack of priority placed by clinicians as well as guidance regarding the identification, education, and management of this condition. PURPOSE: The purpose of this clinical practice guideline is to identify quality improvement opportunities and provide clinicians trustworthy, evidence-based recommendations regarding the identification and management of ARHL. These opportunities are communicated through clear actionable statements with explanation of the support in the literature, evaluation of the quality of the evidence, and recommendations on implementation. The target patients for the guideline are any individuals aged 50 years and older. The target audience is all clinicians in all care settings. This guideline is intended to focus on evidence-based quality improvement opportunities judged most important by the guideline development group (GDG). It is not intended to be a comprehensive, general guide regarding the management of ARHL. The statements in this guideline are not intended to limit or restrict care provided by clinicians based on their experience and assessment of individual patients. ACTION STATEMENTS: The GDG made strong recommendations for the following key action statements (KASs): (KAS 4) If screening suggests hearing loss, clinicians should obtain or refer to a clinician who can obtain an audiogram. (KAS 8) Clinicians should offer, or refer to a clinician who can offer, appropriately fit amplification to patients with ARHL. (KAS 9) Clinicians should refer patients for an evaluation of cochlear implantation candidacy when patients have appropriately fit amplification and persistent hearing difficulty with poor speech understanding. The GDG made recommendations for the following KASs: (KAS 1) Clinicians should screen patients aged 50 years and older for hearing loss at the time of a health care encounter. (KAS 2) If screening suggests hearing loss, clinicians should examine the ear canal and tympanic membrane with otoscopy or refer to a clinician who can examine the ears for cerumen impaction, infection, or other abnormalities. (KAS 3) If screening suggests hearing loss, clinicians should identify sociodemographic factors and patient preferences that influence access to and utilization of hearing health care. (KAS 5) Clinicians should evaluate and treat or refer to a clinician who can evaluate and treat patients with significant asymmetric hearing loss, conductive or mixed hearing loss, or poor word recognition on diagnostic testing. (KAS 6) Clinicians should educate and counsel patients with hearing loss and their family/care partner(s) about the impact of hearing loss on their communication, safety, function, cognition, and quality of life (QOL). (KAS 7) Clinicians should counsel patients with hearing loss on communication strategies and assistive listening devices. (KAS 10) For patients with hearing loss, clinicians should assess if communication goals have been met and if there has been improvement in hearing-related QOL at a subsequent health care encounter or within 1 year. The GDG offered the following KAS as an option: (KAS 11) Clinicians should assess hearing at least every 3 years in patients with known hearing loss or with reported concern for changes in hearing.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Tsai Do BS, Bush ML, Weinreich HM, et al. Clinical Practice Guideline: Age-Related Hearing Loss. Otolaryngol Head Neck Surg. 2024. PMID: 38687845. doi:10.1002/ohn.750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。